Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
19.46
+0.08 (0.41%)
At close: Jan 20, 2026
SHA:605369 Market Cap
SHA:605369 has a market cap or net worth of 4.28 billion as of January 20, 2026. Its market cap has decreased by -6.94% in one year.
Market Cap
4.28B
Enterprise Value
3.89B
Revenue
1.12B
Ranking
n/a
PE Ratio
41.57
Stock Price
19.46
Market Cap Chart
Since September 16, 2020, SHA:605369's market cap has increased from 3.65B to 4.28B, an increase of 17.45%. That is a compound annual growth rate of 3.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 4.27B | 3.86% |
| Dec 31, 2025 | 4.11B | -6.45% |
| Dec 31, 2024 | 4.39B | -30.17% |
| Dec 29, 2023 | 6.29B | -47.15% |
| Dec 30, 2022 | 11.89B | -26.28% |
| Dec 31, 2021 | 16.14B | 249.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |